The Effect of a Novel Viscous Polysaccharide along with Lifestyle Changes on Short-Term Weight Loss and Associated Risk Factors in Overweight and Obese Adults: An Observational Retrospective Clinical Program Analysis

被引:0
作者
Lyon, Michael R. [1 ,2 ]
Reichert, Ronald G. [2 ]
机构
[1] Univ British Columbia, Food Nutr & Hlth Program, Vancouver, BC V5Z 1M9, Canada
[2] Canadian Ctr Funct Med, Coquitlam, BC, Canada
关键词
viscous fiber; weight loss; obesity; BMI; metabolic syndrome; PGX; CHOLESTEROL-LOWERING FOODS; BODY-WEIGHT; BETA-GLUCAN; INSULIN-RESISTANCE; METABOLIC-SYNDROME; DIETARY PORTFOLIO; GUAR GUM; FIBER; EXERCISE; SUPPLEMENTATION;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
BACKGROUND: Viscous soluble dietary fiber has been demonstrated to reduce postprandial glycemia and may promote satiety. PolyGlycopleX (R) (PGX (R)) is a highly viscous polysaccharide manufactured by reacting glucomannan with other soluble polysaccharides using a proprietary process (EnviroSimplex (R)). The resulting polysaccharide (alpha-D-glucurono-alpha-D-manno-beta-D-manno-beta-D-glucan, alpha-L-gulurono-beta-D-mannuronan,beta-D-gluco-beta-D-mannan, alpha-D-glucurono-alpha-D-manno-beta-D-manno-beta-D-gluco, alpha-L-gulurono-beta-D-mannurono, beta-D-gluco-beta-D-mannan) is a novel entity with the highest viscosity and water-holding capacity of currently known fibers. MATERIALS & METHODS: A total of 29 sedentary overweight or obese adults (23 women; six men), ages 20-65 with a body mass index (BMI) range of 25 kg/m(2) to 36 kg/m(2) participated in a clinical weight-loss program. PGX (5 g) was consumed with 500 ml water, 5-10 minutes before each meal, 2-3 times daily for 14 weeks. RESULTS: Significant reductions were observed (p<0.05) in weight (-5.79 +/- 3.55 kg), waist circumference (-12.07 +/- 5.56 cm), and percentage body fat (-2.43 +/- 2.39%) compared to baseline values. In addition, subjects employing PGX had a significant reduction of 19.26 percent (n=17; p<0.05) and 25.51 percent (n=16; p<0.05) in total and LDL plasma cholesterol values, respectively, at the end of the study period. CONCLUSION: The consumption of PGX in concert with lifestyle modifications may be a useful strategy for weight loss in overweight and obese individuals. (Altern Med Rev 2010;15(1):68-75)
引用
收藏
页码:68 / 75
页数:8
相关论文
共 34 条
[1]   Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: A 16 week, double-blind, placebo-controlled trial [J].
Anderson, James W. ;
Schwartz, Susan M. ;
Hauptman, Jonathan ;
Boldrin, Mark ;
Rossi, Maureen ;
Bansal, Vidhu ;
Hale, Cecilia A. .
ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) :1717-1723
[2]  
Birketvedt GS, 2005, MED SCI MONITOR, V11, pPI5
[3]  
BREITMAN P, 2004, 8 ANN CAN DIAB ASS C
[4]   Supplementation of the diet with the functional fiber PolyGlycoplex® is well tolerated by healthy subjects in a clinical trial [J].
Carabin, Ioana G. ;
Lyon, Michael R. ;
Wood, Simon ;
Pelletier, Xavier ;
Donazzolo, Yves ;
Burdock, George A. .
NUTRITION JOURNAL, 2009, 8
[5]   Long-term weight loss after diet and exercise:: a systematic review [J].
Curioni, CC ;
Lourenço, PM .
INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (10) :1168-1174
[6]  
Dixon John B, 2006, Aust Fam Physician, V35, P576
[7]   LOWER SEDENTARY METABOLIC-RATE IN WOMEN COMPARED WITH MEN [J].
FERRARO, R ;
LILLIOJA, S ;
FONTVIEILLE, AM ;
RISING, R ;
BOGARDUS, C ;
RAVUSSIN, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :780-784
[8]   Management of obesity as a chronic disease: Nonpharmacologic, pharmacologic, and surgical options [J].
Fujioka, K .
OBESITY RESEARCH, 2002, 10 :116S-123S
[9]   The Metabolic Syndrome - from Insulin Resistance to Obesity and Diabetes [J].
Gallagher, Emily Jane ;
LeRoith, Derek ;
Karnieli, Eddy .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (03) :559-+
[10]   In vivo imaging of intragastric gelation and its effect on satiety in humans [J].
Hoad, CL ;
Rayment, P ;
Spiller, RC ;
Marciani, L ;
Alonso, BD ;
Traynor, C ;
Mela, DJ ;
Peters, HPF ;
Gowland, PA .
JOURNAL OF NUTRITION, 2004, 134 (09) :2293-2300